﻿<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>123ArticleOnline.com: zoye ford</title><link>https://www.123articleonline.com/rss/author/319981/zoye-ford</link><description>Articles written by zoye ford from 123ArticleOnline.com</description><language>en-us</language><copyright>Copyright (c) 123ArticleOnline.com All rights reserved.</copyright>
<item>
<title>Human Factors Engineering and Usability Testing Services Market by Roots Analysis</title>
<link>https://www.123articleonline.com/articles/1261276/human-factors-engineering-and-usability-testing-services-market-by-roots-analysis</link>
<description>Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers</description>
</item>

<item>
<title>Manufacturing Market Continuous (Small Molecules and Biologics) by Roots Analysis</title>
<link>https://www.123articleonline.com/articles/1263545/manufacturing-market-continuous-small-molecules-and-biologics-by-roots-analysis</link>
<description>Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing</description>
</item>

<item>
<title>Single-Use Bioreactors Market by Roots Analysis</title>
<link>https://www.123articleonline.com/articles/1260110/single-use-bioreactors-market-by-roots-analysis</link>
<description>Single-use bioreactors are a revolutionary product of the process optimization efforts of drug manufacturers, offering a highly flexible approach to rapidly produce multiple drugs, while notably reducing downtime between batches and operational costs</description>
</item>

<item>
<title>The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis</title>
<link>https://www.123articleonline.com/articles/1258155/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-26-billion-in-2030-predicts-roots-analysis</link>
<description>The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years</description>
</item>

<item>
<title>The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis</title>
<link>https://www.123articleonline.com/articles/1258154/the-elastomeric-closures-market-is-projected-to-reach-usd-93-billion-by-2030-growing-at-an-annualized-rate-of-67-claims-roots-analysis</link>
<description>Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential</description>
</item>

<item>
<title>The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030</title>
<link>https://www.123articleonline.com/articles/1263433/the-sting-pathway-targeting-technologies-market-featuring-a-healthy-pipeline-of-therapeutics-is-anticipated-to-be-worth-over-usd-28-billion-by-2030</link>
<description>STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies</description>
</item>
</channel>
</rss>
